{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:10:33Z","timestamp":1760451033046,"version":"build-2065373602"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,14]]},"DOI":"10.7759\/cureus.94557","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:51:21Z","timestamp":1760449881000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Antiphospholipid Syndrome With Thoracic Outlet and Superior Vena Cava Syndromes: A Complex Case of Recurrent Thrombosis"],"prefix":"10.7759","author":[{"given":"Talha A","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Schick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.04.039","article-title":"Reporting standards of the Society for Vascular Surgery for thoracic outlet syndrome","volume":"64","author":"Illig KA","year":"2016","unstructured":"Illig KA, Donahue D, Duncan A, et al.. Reporting standards of the Society for Vascular Surgery for thoracic outlet syndrome. J Vasc Surg. 2016, 64:e23-35. 10.1016\/j.jvs.2016.04.039","journal-title":"J Vasc Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2022.06.026","article-title":"Thoracic outlet syndrome: a review","volume":"31","author":"Panther EJ","year":"2022","unstructured":"Panther EJ, Reintgen CD, Cueto RJ, Hao KA, Chim H, King JJ. Thoracic outlet syndrome: a review. J Shoulder Elbow Surg. 2022, 31:e545-61. 10.1016\/j.jse.2022.06.026","journal-title":"J Shoulder Elbow Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000198474.99876.f0","article-title":"The superior vena cava syndrome: clinical characteristics and evolving etiology","volume":"85","author":"Rice TW","year":"2006","unstructured":"Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006, 85:37-42. 10.1097\/01.md.0000198474.99876.f0","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp067190","article-title":"Superior vena cava syndrome with malignant causes","volume":"356","author":"Wilson LD","year":"2007","unstructured":"Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007, 356:1862-9. 10.1056\/NEJMcp067190","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"171","author":"Ordi-Ros J","year":"2019","unstructured":"Ordi-Ros J, S\u00e1ez-Comet L, P\u00e9rez-Conesa M, et al.. Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann Intern Med. 2019, 171:685-94. 10.7326\/M19-0291","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo V","year":"2018","unstructured":"Pengo V, Denas G, Zoppellaro G, et al.. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018, 132:1365-71. 10.1182\/blood-2018-04-848333","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.04.009","article-title":"Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis","volume":"17","author":"Dufrost V","year":"2018","unstructured":"Dufrost V, Risse J, Reshetnyak T, et al.. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmun Rev. 2018, 17:1011-21. 10.1016\/j.autrev.2018.04.009","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0803977","article-title":"Hereditary angioedema","volume":"359","author":"Zuraw BL","year":"2008","unstructured":"Zuraw BL. Hereditary angioedema. N Engl J Med. 2008, 359:1027-36. 10.1056\/NEJMcp0803977","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno M","year":"2009","unstructured":"Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009, 15:69-78. 10.1016\/j.molmed.2008.12.001","journal-title":"Trends Mol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent P","year":"2012","unstructured":"Valent P, Akin C, Arock M, et al.. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012, 157:215-25. 10.1159\/000328760","journal-title":"Int Arch Allergy Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0712-y","article-title":"Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation","volume":"41","author":"Souyris M","year":"2019","unstructured":"Souyris M, Mej\u00eda JE, Chaumeil J, Gu\u00e9ry JC. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol. 2019, 41:153-64. 10.1007\/s00281-018-0712-y","journal-title":"Semin Immunopathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411215-refractory-antiphospholipid-syndrome-with-thoracic-outlet-and-superior-vena-cava-syndromes-a-complex-case-of-recurrent-thrombosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:51:21Z","timestamp":1760449881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411215-refractory-antiphospholipid-syndrome-with-thoracic-outlet-and-superior-vena-cava-syndromes-a-complex-case-of-recurrent-thrombosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.94557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}